Wealthspire Advisors (New York)’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Buy
+15,184
New +$151K ﹤0.01% 887
2025
Q4
Sell
-1,005
Closed -$12.1K 2483
2025
Q3
$12.1K Hold
1,005
﹤0.01% 1922
2025
Q2
$8.52K Hold
1,005
﹤0.01% 846
2025
Q1
$11.4K Hold
1,005
﹤0.01% 786
2024
Q4
$20.5K Buy
+1,005
New +$29.3K ﹤0.01% 787

Other funds holding RMTI

Wealthspire Advisors (New York)'s RMTI Position: Q1 2026 in Review

Wealthspire Advisors (New York) opened a new position in Rockwell Medical (RMTI) in Q1 2026: 15,184 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #887 among its holdings. This is a return to the name: Wealthspire Advisors (New York) previously reported a position in RMTI as recently as Q3 2025.

Wealthspire Advisors (New York) first reported a position in RMTI in Q4 2024 and has held it in 5 quarters since. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • Wealthspire Advisors (New York) held 15,184 shares of Rockwell Medical worth $136K as of Q1 2026.
  • Rockwell Medical was a new Wealthspire Advisors (New York) position in Q1 2026.
  • Rockwell Medical made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #887 holding.
  • Wealthspire Advisors (New York) first reported a position in Rockwell Medical in Q4 2024 and has held it in 5 quarters since.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.